English  |  正體中文  |  简体中文  |  Items with full text/Total items : 45422/58598 (78%)
Visitors : 2523951      Online Users : 190
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version


    Please use this identifier to cite or link to this item: http://libir.tmu.edu.tw/handle/987654321/6507


    Title: 骨碎補之類黃鹼素對蝕骨細胞活性的影響
    Effect of Flavonoids Isolated from Drynaria fortunei on Osteoclasts Activity
    Authors: 許智政
    Chih Cheng Hsu
    Contributors: 藥學研究所
    Keywords: 骨碎補
    蝕骨細胞
    Drynaria fortunei
    osteoclasts
    osteoprotegerin
    Date: 2004
    Issue Date: 2009-09-11 16:57:49 (UTC+8)
    Abstract: 骨碎補（Gusuibu）為水龍骨科（Polypodiaceae）槲蕨（Drynaria fortunei (Kunze) J. Sm.）之乾燥根莖，根據過去許多的文獻記載，骨碎補為具有預防及治療骨相關疾病的傳統中藥。而根據本實驗室逐年建立之研究模式，骨碎補經活性分析證實對骨母細胞有促進之作用，而其分離之成分(-)-epicatechin-3-O-β-D-allopyranoside，也已於本實驗室證明對骨母細胞，有促進增生的作用 (簡尚志，2002)。本實驗再對骨碎補於蝕骨細胞，與骨質的增生和再吸收作用過程，對其活性機轉作更深入之探討。
    本實驗用Wistar新生老鼠做細胞初代培養，以體外試驗模式探討骨碎補對蝕骨細胞的影響，經由不同時間點的細胞存活率測試（MTT assay），分析酸性磷酸酵素（ACP）和乳酸去氫酵素（LDH）的含量來測量酵素活性。並佐以酒石酸磷酸酵素染色（TRAP stain）觀察蝕骨細胞分化成熟過程的影響；用2'',7''-Dichlorofluorescein（DCF assay）測試蝕骨細胞內活性氧物種；抽取細胞DNA以電泳分析，研究蝕骨細胞凋亡（apoptosis）的表現。另外抽取蝕骨細胞中RNA，以同步定量聚合酶連鎖反應方法（real-time PCR），以TaqMan® probe檢視蝕骨細胞osteoprotegerin（OPG）和RANK-ligand（RANKL）的基因表現，是否具抑制蝕骨細胞活性的作用。
    本實驗將從槲蕨根莖經純化分離出之(-)-epicatechin-3-O-β-D-allopyranoside，已於本實驗室證明對骨母細胞有促進增生的作用。就蝕骨細胞活性測試（MTT assay）而言，當加入(-)-epicatechin-3-O-β-D-allopyranoside (10 μg/mL)培養第七天時即呈現明顯的細胞抑制（p<0.05），且明顯抑制酸性磷酸酵素活性，這情形也表現在抗酒石酸磷酸酵素染色上。從細胞內的氧化壓力分析，(-)-epicatechin-3-O-β-D-allopyranoside促使活性氧物種濃度上升10%，而在細胞apoptosis表現上，實驗組和控制組間，發現並未導致蝕骨細胞有apoptosis的趨向。在RNA表現的方面，(-)-epicatechin-3-O-β-D-allopyranoside讓OPG表現增加並抑制了RANKL，所以有抑制蝕骨細胞的活性。
    由以上的結果可以顯示(-)-epicatechin-3-O-β-D-allopyranoside對於骨質之再吸收有抑制的效果，其在抑制蝕骨細胞成熟和分化，並且降低成熟蝕骨細胞中酸性磷酸酵素的活性，而非經由細胞凋亡的機轉。
    The traditional Chinese medicine: Gusuibu [Drynaria fortunei (Kunze) J. Sm.] (Polypodiaceae) was commonly used to manage disorders of orthopedics and has been claimed to have therapeutic effects on bone healing. In the preliminary study, the Gusuibu and its isolated pure compound: (-)-epicatechin-3-O-β-D-allopyranoside has been elucidated to be capable to enhance the proliferation of osteoblasts. In this study, we tried to further investigate the molecular mechanism of gusuibu on the bone cells metabolism.
    Primary culture of osteoclasts cells were isolated from newborn Wistar rats. The effects of Drynaria fortunei on bone cell viability were determined by the method of MTT assay. The effects on osteoclasts cells activities were analyzed by acid phosphatase (ACP) and lactate dehydrogenase (LDH). The differentiation of osteoclasts was analyzed by tartrate-resistant acid phosphatase stain. The quantification of intracellular reactive oxygen species (ROS) was assayed by 2&apos;&apos;,7&apos;&apos;-Dichlorofluorescein (DCF) method. Moreover, the RNA extracted from osteoclasts cells were applied on the real-time PCR, and then determined by TagMan® probe. The gene expression of OPG (osteoprotegerin) and RANKL (RANK-ligand) could further tell if they have negative influence on activity of osteoclast cells.
    The results showed that the (-)-epicatechin-3-O-β-D-allopyranoside [extracted from the rhizoma of Drynaria fortunei (KUNTZE) J. SMITH (Polypodiaceae)] has an adjuvant on proliferation of osteoblast cells. The 10 μg/mL (-)-epicatechin-3-O-β-D-allopyranoside inhibits the activity of osteoclasts during proliferation stage as manifested in the MTT assay, enzyme activity of ACP and TRAP stain. In the presence of (-)-epicatechin-3-O-β-D-allopyranoside, the intracellular reactive oxygen species level of osteoclasts increased. On the concept of RNA expression, (-)-epicatechin-3-O-β-D-allopyranoside improved the expression of OPG but meanwhile inhibited RANKL. It showed the inhibition of osteoclasts cells activity.
    The potential of (-)-epicatechin-3-O-β-D-allopyranoside on bone resorption was down-regulator on osteoclastic activity and inhibited the acid phosphatase activities but not induced the apoptosis of osteoclasts.
    Data Type: thesis
    Appears in Collections:[School of Pharmacy] Dissertation/Thesis

    Files in This Item:

    File Description SizeFormat
    摘要.doc30KbMicrosoft Word140View/Open
    摘要.pdf764KbAdobe PDF281View/Open
    摘要.ppt122KbMicrosoft Powerpoint211View/Open
    摘要.ps587KbPostscript40View/Open


    All items in TMUIR are protected by copyright, with all rights reserved.

    著作權聲明 Copyright Notice

    • 本平台之數位內容為臺北醫學大學所收錄之機構典藏，包含體系內各式學術著作及學術產出。秉持開放取用的精神，提供使用者進行資料檢索、下載與取用，惟仍請適度、合理地於合法範圍內使用本平台之內容，以尊重著作權人之權益。商業上之利用，請先取得著作權人之授權。

      The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use. Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner.

    • 瀏覽或使用本平台，視同使用者已完全接受並瞭解聲明中所有規範、中華民國相關法規、一切國際網路規定及使用慣例，並不得為任何不法目的使用TMUIR。

      By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in the statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions. Furthermore, users must not use TMUIR for any illegal purposes.

    • 本平台盡力防止侵害著作權人之權益。若發現本平台之數位內容有侵害著作權人權益情事者，煩請權利人通知本平台維護人員([email protected])，將立即採取移除該數位著作等補救措施。

      TMUIR is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff([email protected]). We will remove the work from the repository.

    Back to Top
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback